A cancer research team led by Dean Tang, PhD, found a specific miRNA (or microRNA) molecule that stunts prostate cancer…
Browsing: Acute Lymphoblastic Leukemia
Michael Soulen, MD of Hospital of the University of Pennsylvania gives an update on the RETNET Trial or the Randomized…
Davendra Sohal, MD of Cleveland Clinic outlines the SWOG S1505 Clinical Trial Requirements at ASCO GI 2017
Johanna Bendell, MD of Sarah Cannon Research Institute discusses the Proprietary Neoantigen Identification Technology Platform at the 2017 Gastrointestinal Cancers…
Johanna Bendell, MD of Sarah Cannon Research Institute discusses the RESORCE Trial and how its data can change treatment for…
Johanna Bendell, MD of Sarah Cannon Research Institute discusses the challenges she’s faced in treating pancreatic cancer at the 2017…
Johanna Bendell, MD of Sarah Cannon Research Institute discusses the upcoming trial and drug development in pancreatic and gastrointestinal cancers…
Johanna Bendell, MD of Sarah Cannon Research Institute discusses the phase 3 study in advanced gastric or GE junction cancer…
Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute discusses the DFCI wellness study and how it states that CRC…
Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute gives an overview of the outcomes of the randomized phase 2…
Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute discusses the four consensus molecular subtypes and how they help with…
Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute discusses molecular testing in determining treatment approach for patients with colorectal…
Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute discusses how immunotherapy is being integrated into existing treatments for patients…
Edith P. Mitchell, MD, FACP of Sidney Kimmel Cancer Center discusses how new classifications of gastric cancer subtypes, based on…
Edith P. Mitchell, MD, FACP of Sidney Kimmel Cancer Center gives an overview of the progress to date of the…
Edith P. Mitchell, MD, FACP of Sidney Kimmel Cancer Center discusses how organoids are being used in cancer biology research…
Edith P. Mitchell, MD, FACP of Sidney Kimmel Cancer Center discusses how the Blue Ribbon Panel may help with the…
Edith P. Mitchell, MD, FACP of Sidney Kimmel Cancer Center discusses immunotherapy in colorectal cancer at the 2017 Gastrointestinal Cancers…
David Ilson, MD of Memorial Sloan Kettering gives an overview of the CALGB 80803 PET Assessment to Optimize Neoadjuvant Chemotherapy…
Cynthia Sears, MD of Johns Hopkins University discusses her lecture entitled Microbes, Microbiota, and Colon Cancer from ASCO GI 2017
Alan P. Venook, MD of the University of California San Francisco describes which colorectal patients will benefit the most from…
Ian Chau, MD, FRCP of Royal Marsden Hospital discusses the results of a Phase I Study of Ramucirumab + Pembrolizumab…
Theodore S. Hong, MD of Massachusetts General Hospital discusses the management of recurrent rectal cancer at ASCO Gi 2017
Steven Lin, MD, PhD from MD Anderson Cancer Center discusses Advances in Radiation Therapy: IMRT and Proton Therapy for Esophageal…
Michael Soulen, MD of Hospital of the University of Pennsylvania discusses new data concerning PRRT at ASCO GI 2017.
Davendra Sohal, MD of Cleveland Clinic gives and update on the SWOG S1505 A randomized phase II study of perioperative…
Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses what happens after NETTER-1 in Neuroendocrine Tumor research…
Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses a poster he is presenting at ASCO GI…
Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses the Phase III trial results of NETTER-1 as…
Bertram Wiedenmann, MD, PhD of Charité Universitätsmedizin Berlin? discusses the NETTER-1 results for patients with neuroendocrine tumors received an 18%…
Michael Hall, MD, MS of Fox Chase Cancer Center discusses how a tumors genetics may critically impact treatment options for…
Michael Hall, MD, MS of Fox Chase Cancer Center discusses the future of research and clinical trials in next generation…
Michael Hall, MD of Fox Chase Cancer Center discusses Emerging Technologies for Genetic Testing and in more detail Micro satellite…
Dr. Dale Shepard, MD of Cleveland Clinic gives an update on the The International Watch & Wait database (IWWD) for…
GRACE is pleased to present a series of webcasts with faculty member John Pagel, MD, PhD, DSc, from Swedish Cancer…
GRACE is pleased to present a series of webcasts with faculty member John Pagel, MD, PhD, DSc, from Swedish Cancer…
Daratumumab (DARA), a human CD38 IgG1? monoclonal antibody, has demonstrated single agent efficacy while being highly tolerable as a monotherapy,…
Dr. David Goodrich, Professor of Oncology at Roswell Park Cancer Institute, is co-author of a study offering new insights on…
Raúl Córdoba, MD, PhD, of University Hospital Fundación Jiménez DÃaz, Madrid, Spain, discusses his two main highlights from ASH 2016.…
Raúl Córdoba, MD, PhD, of University Hospital Fundación Jiménez DÃaz, Madrid, Spain, discusses results from a drugdrug interaction study (NCT02381080)…
Launched in July of 2016, SITC presents the newest in a series of videos focusing on immunotherapy for NSCLC patients,…
MPN expert Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center explains how doctors assess patients with…
Over the last 25 years, there has been an explosion of new and vitally important, anticancer drugs. The development of…
Patient Power,Andrew Schorr,Powerful Patients,medical interviews,interviews for patients,patient empowerment,breast cancer,Dr. William Gradishar,Robert H. Lurie Comprehensive Cancer Center,Northwestern University,San Antonio Breast Cancer…
In this Patient Power segment, Andrew Schorr talks with MPN experts Dr. Prithviraj Bose and Dr. Olatoyosi Odenike about the…
At the 2016 American Society of Hematology (ASH) meeting, Dr. Brian Walker of the University of Arkansas for Medical Sciences…
What is the latest news about lymphoma from ASH 2106? Lymphoma expert Dr. John Burke of Rocky Mountain Cancer Centers…
Dr Raajit Rampal, Memorial Sloan Kettering Cancer Center in New York City, interviews with David Wallace, PV Reporter. Discussing clinical…